A lot has happened in the wider world this year, which has seen significant change in both domestic and international politics, tragic environmental and climatic events, and more unsettling social turmoil and insecurity.
For PHG, the open and close of 2024 were marked by our contribution to the Sinker review of the NHS innovation ecosystem in January, with the review finally published in November.
We have held some really successful events throughout the year: the WYNG-Hatton lecture and conference on AI, data and digital health in April, and the meeting on AI and Liability at the end of November were notably well appreciated. This is not all, of course: there have
been academic papers, blogs, collaborations, speaking engagements and placements. We are particularly excited by the steady growth in commissions from new and established clients. Some of this work is less visible than our flagship reports and briefings but all take
considerable thought and application.
Throughout the year, we were also working on our strategic direction for 2025-2030. Identifying priority areas that will guide our thinking over the next five years and reflect how we will address the challenges and opportunities that will be seen in life sciences and health. The strategy is now available to read.
